饮食中的天然黄酸盐:MAO-B对帕金森病的干预
Ashini Singh1, Suman Sinha2, Niraj Kumar Singh1
1Division of Pharmacology, Institute of Pharmaceutical Research, GLA University, Mathura, India.
Chemical biology & drug design
|September 3, 2024
概括
天然黄类药物显示出作为帕金森病 (PD) 治疗的新型MAO-B抑制剂的前景. 本综述探讨了它们提供超越当前限制的新治疗途径的潜力.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 自然产品化学 自然产品化学
背景情况:
- 帕金森病 (PD) 是一种流行的神经退行性疾病,其特点是由于多巴胺基性神经退行导致的运动症状.
- 增加的单胺氧化酶-B (MAO-B) 活性有助于在黑色物质中减少多巴胺,这是PD病变的一个关键因素.
- 目前的MAO-B抑制剂提供症状缓解,但具有局限性和副作用,需要替代治疗.
研究的目的:
- 审查天然黄素作为新型单胺氧化酶-B (MAO-B) 抑制剂的潜在来源,用于帕金森病 (PD).
- 在PD治疗中探索黄类药物的神经保护潜力和多目标治疗方法.
- 讨论开发用于PD的基于黄类药物的疗法所面临的挑战和机会.
主要方法:
- 关于具有MAO-B抑制活性的天然黄类药物的体外和体内研究的文献综述.
- 对PD模型中黄类药物的作用机制和治疗应用的研究分析.
- 检查临床证据和与当前PD治疗和天然产品开发相关的挑战.
主要成果:
- 天然黄类药物表现出显著的MAO-B抑制活性,表明它们作为PD治疗药物的潜力.
- 黄类药物表现出神经保护作用和与PD病理相关的多目标机制.
- 无论是体外还是体外的研究都支持植物性黄胺的治疗前景.
结论:
- 天然黄类化合物代表了开发用于帕金森病的新型MAO-B抑制剂的有希望的储备.
- 基于黄类的疗法为改善治疗策略提供了潜在的潜力,并减少了副作用.
- 对黄类神经保护和多目标方法的进一步研究对于推进PD疗法至关重要.
相关概念视频
01:24Parkinson's Disease: Treatment
239
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
239
01:15Parkinson's Disease: Overview
499
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
499
01:23Antidepressant Drugs: MAOIs and Other Agents
205
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
205
01:29Drugs Affecting Neurotransmitter Synthesis
1.3K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
1.3K
01:25Adrenergic Agonists: Indirect-Acting Agents
1.5K
Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
1.5K
02:59Cancer Prevention
6.1K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
6.1K